A multicentre evaluation of the Medtronic AVE Flexible Iliac Bridge Stent in the iliac arteries (the first study).
OBJECTIVE
To investigate the short term and 6 month outcomes of a recently introduced iliac stent (the Medtronic AVE Flexible Iliac Bridge Stent).


METHODS
One hundred and sixteen patients, 122 limbs from 6 European sites with atherosclerotic occlusive disease were included if they either had a full occlusion or there was a residual gradient >10 mmHg following PTA. Clinical, haemodynamic and Duplex outcomes were recorded to 6 months.


RESULTS
After stent placement there was no residual stenosis >30 and 8.1% of segments had a residual resting gradient of >10 mmHg. There were three local complications and three deaths at 30 days. Primary patency at 30 days and 6 months was 94.1 and 82.7%. Marked clinical improvement occurred in 87.6 and 86.2% at 30 days and 6 months.


CONCLUSIONS
The Medtronic AVE iliac stent has good 30 day and 6 months outcomes supporting the effective use of this device in occlusive disease.
Gaines
P A
PA
Sheffield Vascular Institute, Northern General Hospital, Sheffield S5 7AU, UK. p.a.gaines@sheffield.ac.uk
Schulte
K-L
KL
Müller-Hülsbeck
S
S
Seelen
J
J
Maleux
G
G
van Overhagen
H
H
Cleveland
T J
TJ
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D017130:Angioplasty; D000842:Ankle / Q000098:blood supply; D000925:Anticoagulants / Q000627:therapeutic use; D001157:Arterial Occlusive Diseases / Q000188:drug therapy / Q000503:physiopathology / Q000601:surgery*; D001794:Blood Pressure / Q000502:physiology; D001916:Brachial Artery / Q000503:physiopathology; D004867:Equipment Design; D005060:Europe; D005260:Female; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007083:Iliac Artery / Q000503:physiopathology / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D017063:Outcome Assessment, Health Care; D015607:Stents; D013673:Technology Assessment, Biomedical
D000925:Anticoagulants; D006493:Heparin